Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide

Blood

Volumn 99, Issue 7, 2002, Pages 2342-2350

  Maurice, Marielle ^a,b   Verhoeyen, Els ^a,b   Salmon, Patrick ^a,b   Trono, Didier ^a,b   Russell, Stephen J ^a,b   Cosset, François Loïc ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN G; OKT 3; POLYPEPTIDE; T LYMPHOCYTE ACTIVATING POLYPEPTIDE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE TRANSFER; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

EID: 0036529821     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.7.2342     Document Type: Article

References (56)

1. T-lymphocyte directed gene therapy for ADA-SCIB: Initial trial results after 4 years
2. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients
3. Approaches to gene therapy for human immunodeficiency virus infection
4. Highly efficient gene transfer in naive human T cells with a murine leukemia virus-based vector
5. Retrovirus-mediated gene transfer in primary T lymphocytes: Influence of the transduction/selection process and of ex vivo expansion on the T cell receptor β chain hypervariable region repertoire
6. Human gene therapy
7. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
8. Integration of murine leukemia virus DNA depends on mitosis
9. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes
10. Human immunodeficiency virus infection of cells arrested in the cell cycle
11. Productive human immunodeficiency virus type 1 (HIV-1) infection of non proliferative human cells
12. Lentiviral vectors: Excellent tools for experimental gene transfer and promising candidates for gene therapy
13. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors
14. Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap
15. HIV-1 genome nuclear import is mediated by a central DNA flap
16. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences
17. Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent
18. Diminished human immunodeficiency virus type 1 reverse transcription and nuclear transport in primary macrophages arrested in early G(1) phase of the cell cycle
19. Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes
20. HIV-1 replication is controlled at the level of T cell activation and proviral integration
21. + T cells requires a cyclosporin A-sensitive pathway
22. + T cells are infectible by human immunodeficiency virus but do not release virus after activation
23. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle
24. The role of the cell cycle in HIV-1 infection
25. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells
26. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells
27. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro
28. Nonproductive human immunodeficiency virus type 1 infection in nucleosidetreated Go lymphocytes
29. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes
30. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
31. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
32. Generation of high-titer pseudotyped retroviral vectors with very broad host range
33. Monoclonal antibodies defining distinctive human T cell surface antigens
34. Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity
35. Sequence analysis of amphotropic and 10A1 murine leukemia virus: Close relationship to mink cell focus forming viruses
36. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU
37. Efficient gene delivery to quiescent IL2-dependent cells by murine leukemia virus-derived vectors harboring IL2 chimeric envelopes glycoproteins
38. Retroviral retargeting by envelopes expressing an N-terminal binding domain
39. A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic and amphotropic murine leukemia viruses
40. Modifying the host range properties of retroviral vectors
41. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes
42. Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein
43. Lentiviral-mediated gene transfer into human lymphocytes: Role of HIV-1 accessory proteins
44. Disulfide bonding controls the processing of retroviral envelope glycoproteins
45. Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors
46. The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells
47. + T cells
48. Co-stimulation in T cell responses
49. From TCR engagement to T cell activation: A kinetic view of T cell behavior
50. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro
51. Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-kappa B- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription
52. Ganciclovir-sensitive acute graft-versus-host disease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cells in a bone marrow transplantation setting
53. Growth factors can enhance lymphocyte survival without committing the cell undergo cell division
54. IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation
55. + T cells enables preservation of a naive repertoire
56. + T cells